Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Friday, 19 July, 2019 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours.

Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors.

Simple and sensitive, the assay provides a standardised output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumour tissue and does not require matched normal tissue or normal blood samples.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system

The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd